Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular research and advanced ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
September 26, 2018 — Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic ...
September 26, 2018 — Positive 12-month data from the late-breaking IMPERIAL trial was presented at the 2018 ...
September 25, 2018 – New data demonstrate the correlation between the presence of non-flow-limiting, non-intervened-upon ...
September 25, 2018 — Orchestra BioMed Inc. announced the three-year clinical results from its Sirolimus Angioplasty ...
September 24, 2018 — Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early ...
September 24, 2018 — New data announced at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference, Sept. 21 ...
October 4, 2018 – The Cardiovascular Research Foundation (CRF) had 15 late-breaking trials and 12 late-breaking clinical ...
September 20, 2018 — Cardiac Dimensions announced the company has randomized its first patient in the CARILLON Pivotal ...
September 19, 2018 – The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...
September 17, 2018 — Raymond Kwong, M.D., MPH, from the Harvard Medical School recently presented his findings on a ...
September 7, 2018 — The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival ...
September 7, 2018 — A new Phase 2 clinical trial looks to confirm the efficacy and safety of Thrombolytic Science LLC’s ...
September 6, 2018 — Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart ...
September 6, 2018 — While it is firmly established that the use of one internal thoracic artery can improve life ...